References
- Dvir D. Transcatheter mitral valve-in-valve and valve-in-ring implantations. Data presented at Transcatheter Cardiovascular Therapeutics, 2016: 2016.
- Frerker C, Schmidt T, Schluter M, et al. Transcatheter implantation of aortic valve prostheses into degenerated mitral valve bioprostheses and failed annuloplasty rings: outcomes according to access route and mitral valve academic research consortium (MVARC) criteria. EuroIntervention. 2016;12:1520–1526. doi: 10.4244/EIJ-D-16-00209.
- Sengodan P, Sankaramangalam K, Banerjee K, et al. Outcomes for percutaneous mitral vlave in valves and rings in the transapical and transseptal access routes: a systematic review and pooled analysis. Struct Heart. 2018;2:214–220.
- Guerrero M, Wang D, Vemulapalli S, et al. Clinical outcomes of transcatheter mitral valve replacement for degenerated mitral bioprosthesis (mitral valve-in-valve) and surgical rings (mitral valve-in-ring) in the United States: data from the STS/ACC/TVT registry. Circulation. 2017;136(Suppl. 1):A23079.
- Guerrero M. Data presented as Late Breaking Clinical Trial at Transcatheter Cardiovascular Therapeutics Scientific Symposium, 2017. https://www.tctmd.com/slide/30-day-outcomes-transcatheter-mv-replacement-patients-severe-mitral-valve-disease-secondary ( last accessed February 11, 2018).
- Guerrero M, Pursnani A, Salinger M, et al. 30-Day outcomes of transseptal transcatheter mitral valve replacement for failed surgical bioprostheses (mitral valve-in-valve): the mitral trial (Mitral Implantation of TRAnscatheter vaLves). Circulation. 2017;136(Suppl. 1):A23085.